Seegene Inc - Asset Resilience Ratio

Latest as of June 2026: 24.96%

Seegene Inc (096530) has an Asset Resilience Ratio of 24.96% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Seegene Inc (096530) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

₩316.04 Billion
≈ $214.18 Million USD Cash + Short-term Investments

Total Assets

₩1.27 Trillion
≈ $858.01 Million USD All company assets

Resilience Assessment

Good
Financial Resilience Level

Asset Resilience Ratio Trend (2012–2025)

This chart shows how Seegene Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Seegene Inc balance sheet assets.

Liquid Assets Composition Over Time

This chart breaks down Seegene Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Seegene Inc (096530) long-term investment share to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩0.00 0%
Short-term Investments ₩316.04 Billion 24.96%
Total Liquid Assets ₩316.04 Billion 24.96%

Asset Resilience Insights

  • Good Liquidity Position: Seegene Inc maintains a healthy 24.96% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company has significant short-term investments, indicating active treasury management.

Seegene Inc Industry Peers by Asset Resilience Ratio

Compare Seegene Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
ALK-Abelló A/S
CO:ALK-B
Biotechnology 0.98%
Mirum Pharmaceuticals Inc
NASDAQ:MIRM
Biotechnology 6.89%
Xiamen Amoytop Biotech Co Ltd
SHG:688278
Biotechnology 4.69%
BB Biotech AG
SW:BION
Biotechnology 92.97%
Soleno Therapeutics Inc
NASDAQ:SLNO
Biotechnology 20.15%
Nanobiotix
NASDAQ:NBTX
Biotechnology 4.71%
Wuhan Keqian Biology Co Ltd
SHG:688526
Biotechnology 19.42%
Beijing Konruns Pharmaceutical Co Ltd
SHG:603590
Biotechnology 10.55%

Annual Asset Resilience Ratio for Seegene Inc (2012–2025)

The table below shows the annual Asset Resilience Ratio data for Seegene Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 29.16% ₩360.33 Billion
≈ $244.19 Million
₩1.24 Trillion
≈ $837.48 Million
+7.34pp
2024-12-31 21.81% ₩262.92 Billion
≈ $178.17 Million
₩1.21 Trillion
≈ $816.80 Million
-4.60pp
2023-12-31 26.41% ₩330.50 Billion
≈ $223.98 Million
₩1.25 Trillion
≈ $848.09 Million
-17.00pp
2022-12-31 43.41% ₩603.78 Billion
≈ $409.17 Million
₩1.39 Trillion
≈ $942.51 Million
+11.63pp
2021-12-31 31.78% ₩473.45 Billion
≈ $320.85 Million
₩1.49 Trillion
≈ $1.01 Billion
+2.43pp
2020-12-31 29.35% ₩321.26 Billion
≈ $217.71 Million
₩1.09 Trillion
≈ $741.78 Million
+1.75pp
2019-12-31 27.60% ₩54.01 Billion
≈ $36.60 Million
₩195.72 Billion
≈ $132.63 Million
+4.73pp
2018-12-31 22.87% ₩37.46 Billion
≈ $25.39 Million
₩163.81 Billion
≈ $111.01 Million
+0.02pp
2017-12-31 22.85% ₩37.66 Billion
≈ $25.52 Million
₩164.84 Billion
≈ $111.71 Million
-12.70pp
2016-12-31 35.55% ₩73.80 Billion
≈ $50.01 Million
₩207.62 Billion
≈ $140.70 Million
+22.05pp
2015-12-31 13.50% ₩26.19 Billion
≈ $17.75 Million
₩194.05 Billion
≈ $131.50 Million
+5.12pp
2014-12-31 8.38% ₩11.60 Billion
≈ $7.86 Million
₩138.45 Billion
≈ $93.83 Million
+1.40pp
2013-12-31 6.97% ₩9.00 Billion
≈ $6.10 Million
₩129.04 Billion
≈ $87.45 Million
-2.75pp
2012-12-31 9.73% ₩8.13 Billion
≈ $5.51 Million
₩83.62 Billion
≈ $56.67 Million
--
pp = percentage points

About Seegene Inc

KQ:096530 Korea Biotechnology
Market Cap
$1.04 Billion
₩1.54 Trillion KRW
Market Cap Rank
#8731 Global
#225 in Korea
Share Price
₩33700.00
Change (1 day)
+3.85%
52-Week Range
₩21850.00 - ₩35650.00
All Time High
₩140042.88
About

Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection … Read more